Healthcare
BVCF invests in US-based Jaguar Animal Health
China-focused BVCF has committed $2 million in a Series A round of funding for Jaguar Animal Health, a veterinary drugs developer, with another $3 million to come by the end of the month.
Halifax-backed Envision Pharma acquires Australia's ProScribe
Envision Pharma Group, a scientific communication company backed by US-based private equity firm The Halifax Group, has acquired Australian medical writing firm ProSribe in a move to expand its Asian footprint.
Jungle Ventures backs Singapore's Klinify
Klinify, a Singapore-based electronic medical records management service provider, has received S$770,000 ($604,000) in seed funding round led by Jungle Ventures.
Ventureast leads $3m round in med-tech startup
OneBreath, which makes low-cost portable ventilators, has raised $3 million from the Ventureast Tenet Fund, Villgro, former OnMobile COO Rajiv Kuchhal and BVR Mohan Reddy, founder of Infotech Enterprises, among other investors.
TPG, Carlyle assess exit options for Australia's Healthscope
Healthscope, an Australian hospital operator owned by TPG Capital and The Carlyle Group, looks set for an IPO that could generate proceeds of around A$4 billion ($3.5 billion).
Sequoia invests in China Angel Group hospital
Sequoia Capital has invested in a Series B round of funding for Angel Women’s and Children Hospital, a Chengdu-based hospital chain.
Wakabayashi Fund invests in MIT Holding
Wakabayashi Fund, a private equity firm based in Tokyo and New York, has invested in US healthcare firm MIT Holdings. The financial details of the transaction were not disclosed.
Boston Scientific leads round for VC-backed Amaranth Medical
Amaranth Medical, a medical device manufacturer backed by Singapore’s Bio*One Capital and Phillip Private Equity, has received a Series C round of funding from US-listed Boston Scientific.
India Awards: Exit of the Year – Apollo Hospitals
When Apax Partners first invested in Apollo Hospitals Enterprise, in 2007, “healthcare was a relatively undiscovered space for PE in India, even for the public markets for that matter,” says Shashank Singh, who heads the PE firm’s India office.
BVCF supports anti-viral drug innovation
Since the discovery of RNA interference (RNAi), a natural mechanism for regulating gene expression, in the 1990s, billions of dollars have been invested by the world’s pharmaceutical giants in using this technology to develop therapeutic drugs. A particular...
Asian Healthcare Fund leads Series B for Forus Health
Asian Healthcare Fund (AHF) has led a INR500 million ($8 million) Series B round of investment in Forus Health, a Bangalore-based firm that develops affordable medical technology for eye treatment.
BVCF leads $7.5m Series A for Quark Pharma China JV
China-focused life sciences and healthcare investor BVCF has led a RMB45 million ($7.5 million) Series A round of funding for Kunshan RiboQuark Pharmaceutical Technology, a joint venture established by Quark Pharmaceuticals and Suzhou Ribo Life Science....
Quadria-led consortium buys majority stake in Indian hospital chain
Quadria Capital, German development finance institution DEG and Swedfund have acquired a majority stake in Medica Synergie from ICICI Venture.
Blackstone exits Emcure Pharma to Bain
The Blackstone Group will exit its 2006 investment in India’s Emcure Pharmaceuticals to Bain Capital. Financial terms of the deal were not disclosed but it is reportedly worth INR7 billion ($112.8 million)
Carlyle invests in India's Global Health Private
The Carlyle Group has acquired a minority stake in India’s Global Health Private, owner and operator of Medanta – the Medicity, a super-specialty Medanta hospital in the National Capital Region (NCR) of Delhi. The transaction facilitates the exit of Avenue...
Anacacia completes two deals in health and education
Australian private equity firm Anacacia Capital has completed two new acquisitions in the health and education sectors: healthcare equipment manufacturer Oxford Group and Careers Training Group - formed as a merger between vocational training firms Selmar...
Actis to sell Sterling Hospitals stake back to promoter
Actis will exit a 2006 investment in India’s Sterling Hospitals chain by selling its 82% shareholding back to the founder, Girish Patel. Financial terms of the deal were not disclosed.
Hony-backed China Consun Pharma targets up to $140m for HK IPO
Consun Pharmaceutical Group, a Chinese medicine retailer backed by Hony Capital, is seeking to raise up to HK$1.09 billion ($140 million) through an IPO in Hong Kong.
India Value Fund Advisors invests $24m in Trivitron Healthcare
Trivitron Healthcare has received INR1.5 billion ($24.5 million) from India Value Fund Advisors (IVFA) for a minority stake in the medical technology company.
Matrix Partners India backs TechMed
Matrix Partners India has invested in TechMed, a hospital lab management (HLM) pathology chain, picking up a significant minority stake. The financial details of the transaction were not disclosed.
Japan's VC-backed Oncolys Pharma raises $64m in Tokyo IPO
Oncolys Pharma, a VC-backed developer of drugs targeting cancer and serious infectious diseases, saw its stock open at JPY3,500 per share - a 34.6% premium on the offering price - on its first day of trading in Tokyo. This followed a JPY6.6 billion ($64.4...
KKR agrees capital injection
Before agreeing to invest $200 million in India's Gland Pharma, KKR looked at a couple of opportunities in the injectable drugs space in the US and another in India over a period of several years. The PE firm has a long-standing interest in the industry...
Portea Medical raises $7.6m from Accel, Ventureast
Accel Partners and Ventureast have contributed INR480 million ($7.69 million) in Series A funding for Indian home healthcare provider Portea Medical.
Archer consortium scraps bid for NZ's Abano Healthcare
A consortium of investors including Archer Capital has scrapped its bid for New Zealand's Abano Healthcare Group. The group, which also featured Healthcare Industry Limited (HIL) and Steamboat Capital, cited a downgrade in the company's forecast profit...